Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9824721rdf:typepubmed:Citationlld:pubmed
pubmed-article:9824721lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:9824721lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:9824721lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:9824721lifeskim:mentionsumls-concept:C0026845lld:lifeskim
pubmed-article:9824721lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:9824721lifeskim:mentionsumls-concept:C0205184lld:lifeskim
pubmed-article:9824721lifeskim:mentionsumls-concept:C0205144lld:lifeskim
pubmed-article:9824721pubmed:dateCreated1999-3-3lld:pubmed
pubmed-article:9824721pubmed:abstractText1. Changes in membrane potential following electrical field stimulation (EFS; 1, 2 and 5 pulses at 5 Hz, 0.5 ms duration, 60-80 V) of non-adrenergic non-cholinergic (NANC) inhibitory nerves in the rat isolated anococcygeus muscle were measured using standard intracellular recording techniques. Resting membrane potential ranged between -60 and -70 mV. 2. In the presence of guanethidine (30 microM), atropine (1 microM), propranolol (1 microM) and phentolamine (0.05 microM) to establish NANC conditions, the membrane potential depolarized to between -40 and -50 mV. Under these conditions, EFS caused pulse-dependent, tetrodotoxin (1 microM)-sensitive biphasic inhibitory junction potentials (IJPs) comprising a fast onset and time-to-peak phase followed by a second, slower phase that delayed repolarization. The duration of NANC IJPs ranged between 10 and 20 s. 3. Inhibition of small-conductance Ca2+-activated K+ channels with apamin (0.1 microM) selectively blocked the first fast phase of the NANC IJP, whereas inhibitors of large-conductance Ca2+-activated K+ channels (charybdotoxin and iberiotoxin) and ATP-sensitive K+ channels (glibenclamide) all had no effect on NANC IJPs. 4. Both the nitric oxide synthase inhibitor N G-nitro-L-arginine (L-NOARG; 100 microM) and the inhibitor of soluble guanylate cyclase 1-H-oxodiazol-[1,2,4]-[4,3-a] quinoxaline-1-one (ODQ; 10 microM) had no effect on the first fast phase of the NANC IJP. Each treatment, however, markedly inhibited the slow phase with the duration of the IJP reduced to between 1 and 3 s. The L-NOARG-resistant fast phase of the NANC IJP was almost abolished by the subsequent addition of apamin (0.1 microM). 5. In conclusion, the present study demonstrates unequivocal NANC nerve-mediated biphasic IJPs in the rat isolated anococcygeus. We propose that nitric oxide (NO), via activation of cGMP-dependent K+ channels, and a non-NO inhibitory factor which activates apamin-sensitive K+ channels contribute to NANC nerve-evoked IJPs in the rat anococcygeus.lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:languageenglld:pubmed
pubmed-article:9824721pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:citationSubsetIMlld:pubmed
pubmed-article:9824721pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9824721pubmed:statusMEDLINElld:pubmed
pubmed-article:9824721pubmed:monthDeclld:pubmed
pubmed-article:9824721pubmed:issn0022-3751lld:pubmed
pubmed-article:9824721pubmed:authorpubmed-author:CocksT MTMlld:pubmed
pubmed-article:9824721pubmed:authorpubmed-author:ZiogasJJlld:pubmed
pubmed-article:9824721pubmed:authorpubmed-author:SelemidisSSlld:pubmed
pubmed-article:9824721pubmed:issnTypePrintlld:pubmed
pubmed-article:9824721pubmed:day15lld:pubmed
pubmed-article:9824721pubmed:volume513 ( Pt 3)lld:pubmed
pubmed-article:9824721pubmed:ownerNLMlld:pubmed
pubmed-article:9824721pubmed:authorsCompleteYlld:pubmed
pubmed-article:9824721pubmed:pagination835-44lld:pubmed
pubmed-article:9824721pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:9824721pubmed:meshHeadingpubmed-meshheading:9824721-...lld:pubmed
pubmed-article:9824721pubmed:meshHeadingpubmed-meshheading:9824721-...lld:pubmed
pubmed-article:9824721pubmed:meshHeadingpubmed-meshheading:9824721-...lld:pubmed
pubmed-article:9824721pubmed:meshHeadingpubmed-meshheading:9824721-...lld:pubmed
pubmed-article:9824721pubmed:meshHeadingpubmed-meshheading:9824721-...lld:pubmed
pubmed-article:9824721pubmed:meshHeadingpubmed-meshheading:9824721-...lld:pubmed
pubmed-article:9824721pubmed:meshHeadingpubmed-meshheading:9824721-...lld:pubmed
pubmed-article:9824721pubmed:meshHeadingpubmed-meshheading:9824721-...lld:pubmed
pubmed-article:9824721pubmed:meshHeadingpubmed-meshheading:9824721-...lld:pubmed
pubmed-article:9824721pubmed:meshHeadingpubmed-meshheading:9824721-...lld:pubmed
pubmed-article:9824721pubmed:meshHeadingpubmed-meshheading:9824721-...lld:pubmed
pubmed-article:9824721pubmed:meshHeadingpubmed-meshheading:9824721-...lld:pubmed
pubmed-article:9824721pubmed:meshHeadingpubmed-meshheading:9824721-...lld:pubmed
pubmed-article:9824721pubmed:meshHeadingpubmed-meshheading:9824721-...lld:pubmed
pubmed-article:9824721pubmed:meshHeadingpubmed-meshheading:9824721-...lld:pubmed
pubmed-article:9824721pubmed:meshHeadingpubmed-meshheading:9824721-...lld:pubmed
pubmed-article:9824721pubmed:year1998lld:pubmed
pubmed-article:9824721pubmed:articleTitleApamin- and nitric oxide-sensitive biphasic non-adrenergic non-cholinergic inhibitory junction potentials in the rat anococcygeus muscle.lld:pubmed
pubmed-article:9824721pubmed:affiliationDepartment of Pharmacology, Triradiate Building, University of Melbourne, Parkville, Victoria 3052, Australia.lld:pubmed
pubmed-article:9824721pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9824721pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed